Lates News

Every economic AI flash news, Huayuan Securities released a research report on August 27th, giving Wanmei Biology (603983.SH) a buy rating. The reasons for the rating mainly include: 1) Continuously promoting the high-quality development of dual-brand synergy; 2) The online channel is gaining momentum, and refined operation is carried out on multiple platforms; 3) The company's profitability has decreased slightly, and the sales expense ratio has continued to rise. (Daily Economic News)